BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Diagnosis
22 results:

  • 1. [A Case of Suspected Lynch Syndrome Due to Radical Resection for Descending Colon Cancer and Renal Pelvic Cancer].
    Enoki Y; Kameyama H; Uehara H; Iwaya A; Yamazaki T; Ishii S; Takamatsu Y; Tomizawa G; Sudo N; Katada T; Kobayashi K; Sato D; Sakata E; Yokoyama N; Kuwabara S
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1547-1549. PubMed ID: 36733130
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tuberous sclerosis complex: a complex case.
    Powell RM; Pattison S; Moravec JC; Bhat B; Guirguis N; Markie D; Jones GT; Copedo J; Print CG; Morison IM; Gavryushkin A; Gray B; Wyeth LJ; Eccles MR; Macaulay EC
    Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483879
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report.
    Tomonari M; Shimada M; Nakada Y; Yamamoto I; Itoh M; Koike Y; Kobayashi A; Miki J; Yamada H; Kimura T; Saito S; Sugano K; Sekine S; Yamamoto H; Asahina A; Yokoo T
    BMC Nephrol; 2019 Oct; 20(1):394. PubMed ID: 31664942
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Resolution of Benign and Malignant Sebaceous Neoplasms, in a Renal Transplant Patient Treated With Everolimus.
    Donati M; Paolino G; Muscardin L; Panetta C; Donati P
    Exp Clin Transplant; 2017 Feb; 15(1):100-102. PubMed ID: 25924010
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. DNA repair genes and prognosis in sporadic forms of urothelial carcinoma of the upper urinary tract.
    García-Tello A; Ramón de Fata F; Andrés G; Ropero S; López JI; Angulo JC
    Actas Urol Esp; 2014 Nov; 38(9):600-7. PubMed ID: 24958312
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Primary mucinous adenocarcinoma of the renal pelvis with carcinoma in situ in the ureter.
    Abbas M; Kramer MW; Spieker T; Herrman TR; Merseburger AS; Müller KM; Kuczyk MA; Becker JU; Kreipe HH
    J Egypt Natl Canc Inst; 2014 Mar; 26(1):51-4. PubMed ID: 24565683
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?
    Dadone B; Ambrosetti D; Carpentier X; Duranton-Tanneur V; Burel-Vandenbos F; Amiel J; Pedeutour F
    Cancer Genet; 2013; 206(9-10):347-52. PubMed ID: 24432405
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer.
    Garre P; Martín L; Bando I; Tosar A; Llovet P; Sanz J; Romero A; de la Hoya M; Díaz-Rubio E; Caldés T
    Fam Cancer; 2014 Mar; 13(1):109-19. PubMed ID: 24061861
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28].
    See WA
    Urol Oncol; 2013 Jul; 31(5):716. PubMed ID: 23796201
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome.
    Win AK; Lindor NM; Winship I; Tucker KM; Buchanan DD; Young JP; Rosty C; Leggett B; Giles GG; Goldblatt J; Macrae FA; Parry S; Kalady MF; Baron JA; Ahnen DJ; Marchand LL; Gallinger S; Haile RW; Newcomb PA; Hopper JL; Jenkins MA
    J Natl Cancer Inst; 2013 Feb; 105(4):274-9. PubMed ID: 23385444
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.
    Win AK; Lindor NM; Young JP; Macrae FA; Young GP; Williamson E; Parry S; Goldblatt J; Lipton L; Winship I; Leggett B; Tucker KM; Giles GG; Buchanan DD; Clendenning M; Rosty C; Arnold J; Levine AJ; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Hopper JL; Jenkins MA
    J Natl Cancer Inst; 2012 Sep; 104(18):1363-72. PubMed ID: 22933731
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Soft tissue sarcoma and the hereditary non-polyposis colorectal cancer (hnpcc) syndrome: formulation of an hypothesis.
    Urso E; Agostini M; Pucciarelli S; Bedin C; D'angelo E; Mescoli C; Viel A; Maretto I; Mammi I; Nitti D
    Mol Biol Rep; 2012 Oct; 39(10):9307-10. PubMed ID: 22782591
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Uroepithelial and kidney carcinoma in Lynch syndrome.
    Aarnio M; Säily M; Juhola M; Gylling A; Peltomäki P; Järvinen HJ; Mecklin JP
    Fam Cancer; 2012 Sep; 11(3):395-401. PubMed ID: 22476430
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Metachronous urothelial cancer in bilateral upper urinary tracts and bladder associated with hereditary nonpolyposis colorectal cancer].
    Yamada Y; Ueda Y; Higuchi Y; Suzuki T; Maruyama T; Kondoh Y; Nojima M; Noda M; Tomita N; Zozumi M; Hirota S; Yamamoto S
    Hinyokika Kiyo; 2011 Oct; 57(10):559-63. PubMed ID: 22089154
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.
    Landis MN; Davis CL; Bellus GA; Wolverton SE
    J Am Acad Dermatol; 2011 Nov; 65(5):1054-1058.e1. PubMed ID: 21550136
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Upper urinary tract carcinoma in Lynch syndrome cases.
    Crockett DG; Wagner DG; Holmäng S; Johansson SL; Lynch HT
    J Urol; 2011 May; 185(5):1627-30. PubMed ID: 21419447
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
    Rouprêt M; Yates DR; Comperat E; Cussenot O
    Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (hnpcc).
    Geary J; Sasieni P; Houlston R; Izatt L; Eeles R; Payne SJ; Fisher S; Hodgson SV
    Fam Cancer; 2008; 7(2):163-72. PubMed ID: 17939062
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families.
    Ponti G; Ponz de Leon M; Losi L; Di Gregorio C; Benatti P; Pedroni M; Scarselli A; Riegler G; Lembo L; Pellacani G; Seidenari S; Rossi G; Roncucci L
    Br J Dermatol; 2005 Jun; 152(6):1335-8. PubMed ID: 15949004
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
    Rouprêt M; Fromont G; Azzouzi AR; Catto JW; Vallancien G; Hamdy FC; Cussenot O
    Urology; 2005 Jun; 65(6):1233-7. PubMed ID: 15922421
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.